FDA Okays Once-Daily Tardive Dyskinesia, Huntington Chorea Drug

The US Food and Drug Administration has approved deutetrabenazine extended-release tablets (Austedo XR) for tardive dyskinesia or chorea related to Huntington disease.
Medscape Medical News